NCT04739124

Brief Summary

Following the proposal to self-monitor by the Freestyle Libre® (FSL) connected object, in diabetic patients in the context of therapeutic education, regarding the appropriation of FSL, what works, for which patients , in what specific contexts and by what mechanisms does it govern? A multicentric observational research will be conducted with mixed method design (follow-up using patient questionnaires) and semi-structured interviews of patients and caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

June 10, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2023

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

2.2 years

First QC Date

February 1, 2021

Last Update Submit

September 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between appropriation factors, intention to use, Freestyle Libre use and glycemic control

    longitudinal multifactor analysis by structural equation modeling of the research model created specifically

    3 months

Study Arms (2)

Diabetic patients

Patients presenting type 1 or type 2 diabetes, eligible for the prescription of Freestyle Libre

Other: Follow-up questionnairesOther: Interviews

Caregivers

Caregiver caring for diabetic patients and practicing therapeutic education on a regular basis

Other: Follow-up questionnaires

Interventions

The patient normally follows the education program as usual but research specific data is collected: * Biological sampling at the start and end of the education program (glycated hemoglobin). * Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use) * Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)

CaregiversDiabetic patients

Semi-structured interviews will be carried out during the visits, either face-to-face or remotely.

Diabetic patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be composed of diabetic patients and their caregivers.

You may qualify if:

  • Patients
  • Have type 1 or type 2 diabetes (as included in the education program),
  • Be of legal age (over 18 years old),
  • Do not present legal protection measures due to incapacity (such as guardianship or guardianship).
  • Be able to read and speak French (elementary school level)
  • Be eligible for FSL prescription and authorize the sharing of your data in Libreview®
  • Be affiliated to a social security scheme
  • Have an email address or a phone allowing internet use
  • Caregivers
  • Be registered on the roll of his professional order
  • Hold the certificate of 40 hours of training in therapeutic education.
  • Practice therapeutic education on a regular basis

You may not qualify if:

  • Patients
  • presenting contraindications to the use of Freestyle Libre® (known allergies to adhesive products, coagulation disorders, not treated with insulin therapy or with less than 3 insulin injections per day or continuously, not requiring glycemic monitoring or less than 3 times a day)
  • Patient refusing to follow the education program,
  • Minors, patients under administrative or judicial supervision)
  • Pregnant women,
  • Patients who cannot be contacted in an emergency,
  • Persons in a position to give their consent but with an inability to read / write the French language.
  • Patients who do not have an email address or a phone allowing internet use.
  • Caregivers
  • Failure to register with the professional order (except those of the Army Health Service who are exempt)
  • Non-possession of the 40-hour therapeutic education training certificate.
  • Not practicing FSL education

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpital Avicenne

Bobigny, 93009, France

Location

Hopital d'Instruction des Armées Bégin

Saint-Mandé, 94163, France

Location

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2021

First Posted

February 4, 2021

Study Start

June 10, 2021

Primary Completion

September 6, 2023

Study Completion

September 6, 2023

Last Updated

September 21, 2023

Record last verified: 2023-09

Locations